EUVIMEDEUVIMED entdecken
Crossref

Whole genome sequencing as a first‐tier diagnostic test for infants in neonatal intensive care units: A pilot study in Brazil

Michele P Migliavacca, Joselito Sobreira iD, Diana Bermeo, Mireille Gomes, Dayse Alencar, Luciane Sussuchi, Camila Alves Souza, Juliana Santos Silva, José Eduardo Kroll, Matheus Burger, Rodrigo Guarischi-Sousa iD, Darine Villela iD und 16 weitere

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Michele P Migliavacca und 27 weiteren Autor:innen. Beteiligte Einrichtung: Diagnósticos da América S.A., DASA, São Paulo, Brazil. Hauptthemen laut MEDLINE: Whole Genome Sequencing, Intensive Care Units, Neonatal, Genetic Testing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this pilot study, we aimed to evaluate the feasibility of whole genome sequencing (WGS) as a first‐tier diagnostic test for infants hospitalized in neonatal intensive care units in the Brazilian healthcare system. The cohort presented here results from a joint collaboration between private and public hospitals in Brazil considering the initiative of a clinical laboratory to provide timely diagnosis for critically ill infants. We performed trio (proband and parents) WGS in 21 infants suspected of a genetic disease with an urgent need for diagnosis to guide medical care. Overall, the primary indication for genetic testing was dysmorphic syndromes ( n = 14, 67%) followed by inborn errors of metabolism ( n = 6, 29%) and skeletal dysplasias ( n = 1, 5%). The diagnostic yield in our cohort was 57% (12/21) based on cases that received a definitive or likely definitive diagnostic result from WGS analysis. A total of 16 pathogenic/likely pathogenic variants and 10 variants of unknown significance were detected, and in most cases inherited from an unaffected parent. In addition, the reported variants were of different types, but mainly missense (58%) and associated with autosomal diseases (19/26); only three were associated with X‐linked diseases, detected in hemizygosity in the proband an inherited from an unaffected mother. Notably, we identified 10 novel variants, absent from public genomic databases, in our cohort. Considering the entire diagnostic process, the average turnaround time from enrollment to medical report in our study was 53 days. Our findings demonstrate the remarkable utility of WGS as a diagnostic tool, elevating the potential of transformative impact since it outperforms conventional genetic tests. Here, we address the main challenges associated with implementing WGS in the medical care system in Brazil, as well as discuss the potential benefits and limitations of WGS as a diagnostic tool in the neonatal care setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Whole Genome SequencingIntensive Care Units, NeonatalGenetic TestingHumansBrazilInfant, NewbornMaleFemalePilot ProjectsInfantGenetic Diseases, Inborn

Stichwörter der Autor:innen

clinical pediatricsdiagnostic yieldgenetic diseasesnext‐generation sequencing (NGS)trio testingwhole genome sequencing

Autor:innen und Institutionen

  • Diagnósticos da América S.A., DASA, São Paulo, Brazil.
  • Hospital Infantil Sabará, São Paulo, Brazil.
  • Instituto da Criança, Faculdade de Medicina (FMUSP), Universidade de São Paulo, São Paulo, Brazil.
  • Hospital das Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.
  • McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Joselito Sobreira, Rodrigo Guarischi-Sousa, Darine Villela, Nara Sobreira

Zitieren

APA

Migliavacca, M. P., Sobreira, J., Bermeo, D., Gomes, M., Alencar, D., Sussuchi, L., Souza, C. A., Silva, J. S., Kroll, J. E., Burger, M., Guarischi-Sousa, R., Villela, D., Yamamoto, G. L., Milanezi, F., Horigoshi, N., Cesar, R. G., de Carvalho, W. B., Honjo, R. S., Bertola, D. R., …, & Sobreira, N. (2024). Whole genome sequencing as a first‐tier diagnostic test for infants in neonatal intensive care units: A pilot study in Brazil. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63544

Vancouver

Migliavacca MP, Sobreira J, Bermeo D, Gomes M, Alencar D, Sussuchi L, et al. Whole genome sequencing as a first‐tier diagnostic test for infants in neonatal intensive care units: A pilot study in Brazil. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63544

BibTeX
@article{Migliavacca2024,
  author = {Migliavacca, Michele P and Sobreira, Joselito and Bermeo, Diana and Gomes, Mireille and Alencar, Dayse and Sussuchi, Luciane and Souza, Camila Alves and Silva, Juliana Santos and Kroll, José Eduardo and Burger, Matheus and Guarischi-Sousa, Rodrigo and Villela, Darine and Yamamoto, Guilherme L and Milanezi, Fernanda and Horigoshi, Nelson and Cesar, Regina Grigolli and de Carvalho, Werther Brunow and Honjo, Rachel Sayuri and Bertola, Debora Romeo and Kim, Chong Ae and de Souza, Lucian and Procianoy, Renato S and Silveria, Rita C and Rosenberg, Carla and Giugliani, Roberto and Campana, Gustavo Aguiar and Scapulatempo-Neto, Cristovam and Sobreira, Nara},
  title = {Whole genome sequencing as a first‐tier diagnostic test for infants in neonatal intensive care units: A pilot study in Brazil},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63544}
}
Kostenlos starten →